🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
INS
$INSM
🔒 US EquitiesInsmed Incorporated
AVG HISTORICAL GAP
-2.41%
MAX GAP RECORD
-14.72%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $INSM
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$INSM
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (UNDETERMINED) |
+0.00%
|
| May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN) |
-14.72%
|
| Feb 19, 2026 Earnings Release 2026-02-19 (BEFORE OPEN) |
+1.77%
|
| Oct 30, 2025 Earnings Release 2025-10-30 (BEFORE OPEN) |
+2.58%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN) |
-4.23%
|
| May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN) |
+0.00%
|
| Feb 20, 2025 Earnings Release 2025-02-20 (BEFORE OPEN) |
-4.45%
|
| Oct 31, 2024 Earnings Release 2024-10-31 (BEFORE OPEN) |
-2.43%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.2%
Bullish Gaps (2)
Bearish Gaps (9)
Neutral / Flat (2)
📖 Intelligence Summary
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗